ReviewCentral European journal of urology2024
Body mass index, obesity and risk of prostate cancer: a systematic review and meta-analysis.
Review in Central European journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association between overweight and obesity determined by body mass index and overall survival in patients with metastatic prostate cancer: a meta-analysis.International journal of obesity (2005) · 2025Pooled it
- Association Between Psoriasis and Prostate Cancer Risk in Men: A Retrospective Cohort Study.Journal of epidemiology and global health · 2026Article
- Predicting Prostate Cancer Risk and Its Associated Factors Using Machine Learning Techniques: A Retrospective Study.Health science reports · 2026Article
- Obesity and Cancer: Mechanisms, Epidemiological Evidence, and Potential Risk Reduction.Journal of obesity & metabolic syndrome · 2026Review
- Does body mass index affect the proper pre-operative grade and stage assessment in patients with prostate cancer undergoing radical prostatectomy?Central European journal of urology · 2026Article
- Normal Weight, Overweight and Obesity Conditions Associated to Prostate Neoplasm Stages-A Systematic Review and Meta-Analysis.Biomedicines · 2025Review
- May Patients Receiving GLP-1 Agonists Be at Lower Risk of Prostate Cancer Aggressiveness and Progression?Cancers · 2025Review
- From pituitary cells to prostate gland in health and disease: direct and indirect endocrine connections.Reviews in endocrine & metabolic disorders · 2025Review
- Periprostatic Adipose Tissue as a Contributor to Prostate Cancer Pathogenesis: A Narrative Review.Cancers · 2025Review
- Article
- Human papillomavirus infection among men and its role in the etiology of prostate cancer: A prospective study.Central European journal of urology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Prostate cancer (PCa) is one of the most diagnosed cancer in male. Body mass index (BMI) has been linked to the risk of cancer and its mortality. Our objective was to undertake a quantitative analysis elucidating the relationship between BMI and the risk of PCa. Material and methods: A literature search was conducted in PubMed, ProQuest, and EMBASE using relevant keywords and phrases. BMI was classified as underweight (BMI <18.5 kg/m Results: A total of 13 studies were included in quantitative analysis. Underweight patients exhibited a decreased risk of PCa compared to those with normal weight (RR: 0.44; 95% CI 0.04-5.08; p = 0.51). Higher BMI has been associated with higher risk of PCa among overweight patients (RR: 1.08; 95% CI 1.06-1.11; p <0.00001) and obese patients (RR: 1.12; 95% CI 1.07-1.17; p <0.00001) respectively. The combined analysis of overweight and obese individuals also indicated a heightened risk of PCa (RR: 1.02; 95% CI 1.04-1.11; p <0.0001). Mortality rates were higher in overweight and obese individuals, though not statistically significant (RR 1.15; 95% CI 0.88-1.52; p = 0.31). Conclusions: BMI >25 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.